Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6124426 | Osteoarthritis and Cartilage | 2016 | 10 Pages |
Abstract
At $100,000/QALY, Tanezumab would be cost effective if priced â¤$400/dose in all settings except IV hospital delivery.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
E. Losina, G. Michl, J.E. Collins, D.J. Hunter, J.M. Jordan, E. Yelin, A.D. Paltiel, J.N. Katz,